Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$109.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 29 most recent Form 4 transactions.
| Jun 4 | KURA | Kura Oncology, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 43,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 47,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 325,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 650,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 544,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 544,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 437,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 1.5M | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 43,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 47,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 325,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 650,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 544,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 544,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 437,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 1.3M | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 1.5M | — | — | — | Open the original filing on SEC.gov |
| Mar 19 | GOSS | Gossamer Bio, Inc. | DTOISS◆ | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT◆ | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | GOSS | Gossamer Bio, Inc. | AGRANT | 280,000 | — | — | +50.2% | Open the original filing on SEC.gov |
| Dec 9, 2025 | KURA | Kura Oncology, Inc. | SSELL◷? | 10,000 | $10.98 | $109.8K | -29.4% | Open the original filing on SEC.gov |
| Dec 9, 2025 | KURA | Kura Oncology, Inc. | MEXER◷? | 10,000 | $3.12 | $31.2K | +41.7% | Open the original filing on SEC.gov |
| Oct 1, 2025 | GOSS | Gossamer Bio, Inc. | AGRANT | 437,500 | — | — | +363.7% | Open the original filing on SEC.gov |
| Jun 5, 2025 | KURA | Kura Oncology, Inc. | AGRANT◆ | 28,500 | — | — | — | Open the original filing on SEC.gov |